Group A Streptococcus (GAS) is a
type of gram-positive B-hemolytic Streptococcus bacteria. These bacteria are
capable of causing a wide range of both non-invasive and invasive infections.
GAS infection might spread through direct contact with skin sores or mucus of a
infected person. Despite the emergence of wide range effective and safe
antibiotics as a treatment regimen for GAS, infection caused by GAS is
increasing significantly across the world.
Read Report Overview
- https://www.transparencymarketresearch.com/molecular-diagnostic-market.html
However, with the use of advance
molecular diagnosis kits and technologies, the progression of the infections
can be slowed down to a significantly, which will ultimately reduce the
recovery time of the patient. Currently,
molecular diagnostic market for GAS NA test is a lucrative market venture due
to high patient preference and increasing base of patients suffering from
Streptococcal infections, which makes this industry a highly profitable and
attractive market.
Some of the molecular diagnostic
techniques generally used for group A Streptococcus (GAS) NA tests are as
follows:
·
·
·
·
In the geographical analysis,
North America is the largest market for molecular diagnostic kits for group A
Streptococcus tests owing to the high incidence rate of Streptococcal
infections and diseases. According to the Centers for Disease Control and
Prevention (CDC), each year, nearly 11,000 people suffer from invasive GAS
infections and approximately 10 million people suffer from non-invasive GAS
infections, in the U.S.
Request Brochure of
Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2479
However, other regions such as
South East Asia, Latin America and Middle East are expected to be the promising
markets in the near future. Owing to the rising disposable income among
population and high adoption rate for advanced molecular diagnostics kits and
technologies, these regions are expected to be the potential market in the near
future.
The overall molecular diagnostic
market for group A Streptococcus (GAS) NA tests is experiencing an admirable
growth; due to the increasing incidence rate of group A Streptococcus
infections, such as pharyngitis, tonsillitis and fever. Moreover, large base of
patients affected from streptococcal infections including both geriatric
population and youth is expected to drive the growth of various molecular
diagnostic kits that are used for group A Streptococcus tests.
Request for Custom
Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2479
It has also been estimated that,
this market is shows potential to be a lucrative and expanding field due the
increasing adoption rate for advanced diagnostic technologies and services.
Expected technological breakthroughs will generate abundant opportunities for
molecular diagnostic kits that could be used for detecting targeted
Streptococcal bacteria, which causes the infections. For instance, Japan based
Otsuka Pharmaceutical Co., Ltd. launched a rapid diagnostic test kit,
\"QuickNavi Strep A\" for rapid detection of beta-hemolytic group A
Streptococcus on 14 April 2014.
However, rise in overall
healthcare expenditure, stringent reimbursement policies and high development
costs are some of the market-restraining factors that might hinder the growth
of molecular diagnostic kits market for group A Streptococcus (GAS) NA tests in
future.
Pre Book Molecular
Diagnostic Market for Group A Streptococcus (GAS) NA Tests Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=2479<ype=S
Currently, the molecular
diagnostic market for Group A Streptococcus (GAS) NA tests is a highly
fragmented market owing to the involvement of many established and emerging
players in the market. Some of the companies involved with development and
commercialization of amplification and detection platforms for performing these
tests are Abbott Laboratories, Applied Biosystems, Bio-Rad Laboratories, Inc.,
bioMérieux, Cepheid, Inc., Digene Corporation, Otsuka Pharmaceutical Co., Ltd.,
Qiagen, Roche Diagnostics Corporation, Siemens AG and Stratagene Corporation
(Agilent Technologies Inc.)
About Us
Transparency Market Research is a
global market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for several decision makers.
Our experienced team of analysts, researchers, and consultants use proprietary data
sources and various tools and techniques to gather and analyze information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material
for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
